Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
Crossref DOI link: https://doi.org/10.1186/s40413-014-0050-z
Published Print: 2014
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carrillo, Diana C.
Borges, Mario Sanchez
GarcĂa, Elizabeth
Egea, Eduardo
Serrano, Carlos D.
Text and Data Mining valid from 2014-01-01
Version of Record valid from 2019-04-24
License valid from 2014-01-01